Liver Iron Loading in Alcohol-Associated Liver Disease
- PMID: 36306827
- PMCID: PMC12178325
- DOI: 10.1016/j.ajpath.2022.08.010
Liver Iron Loading in Alcohol-Associated Liver Disease
Abstract
Alcohol-associated liver disease (ALD) is a common chronic liver disease with increasing incidence worldwide. Alcoholic liver steatosis/steatohepatitis can progress to liver fibrosis/cirrhosis, which can cause predisposition to hepatocellular carcinoma. ALD diagnosis and management are confounded by several challenges. Iron loading is a feature of ALD which can exacerbate alcohol-induced liver injury and promote ALD pathologic progression. Knowledge of the mechanisms that mediate liver iron loading can help identify cellular/molecular targets and thereby aid in designing adjunct diagnostic, prognostic, and therapeutic approaches for ALD. Herein, the cellular mechanisms underlying alcohol-induced liver iron loading are reviewed and how excess iron in patients with ALD can promote liver fibrosis and aggravate disease pathology is discussed. Alcohol-induced increase in hepatic transferrin receptor-1 expression and up-regulation of high iron protein in Kupffer cells (proposed) facilitate iron deposition and retention in the liver. Iron is loaded in both parenchymal and nonparenchymal liver cells. Iron-loaded liver can promote ferroptosis and thereby contribute to ALD pathology. Iron and alcohol can independently elevate oxidative stress. Therefore, a combination of excess iron and alcohol amplifies oxidative stress and accelerates liver injury. Excess iron-stimulated hepatocytes directly or indirectly (through Kupffer cell activation) activate the hepatic stellate cells via secretion of proinflammatory and profibrotic factors. Persistently activated hepatic stellate cells promote liver fibrosis, and thereby facilitate ALD progression.
Copyright © 2023 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.
Figures



Comment in
-
The Cellular, Molecular, and Pathologic Consequences of Stress on the Liver.Am J Pathol. 2023 Oct;193(10):1353-1354. doi: 10.1016/j.ajpath.2023.07.003. Epub 2023 Aug 4. Am J Pathol. 2023. PMID: 37544504 Free PMC article. No abstract available.
Similar articles
-
Ferroptosis and gut microbiota: A new horizon in alcohol-associated liver disease management.Cell Mol Life Sci. 2025 Jul 19;82(1):282. doi: 10.1007/s00018-025-05815-5. Cell Mol Life Sci. 2025. PMID: 40682668 Free PMC article. Review.
-
Refining the Rab7-V1G1 axis to mitigate iron deposition: Protective effects of quercetin in alcoholic liver disease.J Nutr Biochem. 2025 Jan;135:109767. doi: 10.1016/j.jnutbio.2024.109767. Epub 2024 Sep 14. J Nutr Biochem. 2025. PMID: 39284533
-
Key Signaling in Alcohol-Associated Liver Disease: The Role of Bile Acids.Cells. 2022 Apr 18;11(8):1374. doi: 10.3390/cells11081374. Cells. 2022. PMID: 35456053 Free PMC article. Review.
-
Ceramide kinase suppresses ferroptosis and protects against alcohol-associated liver disease through the p38 MAPK-HSPB1 pathway.Hepatol Commun. 2025 Jun 19;9(7):e0731. doi: 10.1097/HC9.0000000000000731. eCollection 2025 Jul 1. Hepatol Commun. 2025. PMID: 40536506 Free PMC article.
-
Modulatory effects of CNNM4 on protein- l -isoaspartyl- O -methyltransferase repair function during alcohol-induced hepatic damage.Hepatology. 2025 Aug 1;82(2):388-404. doi: 10.1097/HEP.0000000000001156. Epub 2024 Nov 19. Hepatology. 2025. PMID: 39641635 Free PMC article.
Cited by
-
Immunological mechanisms in steatotic liver diseases: An overview and clinical perspectives.Clin Mol Hepatol. 2024 Oct;30(4):620-648. doi: 10.3350/cmh.2024.0315. Epub 2024 Jul 11. Clin Mol Hepatol. 2024. PMID: 38988278 Free PMC article. Review.
-
ACSS2 protects against alcohol-induced hepatocyte ferroptosis through regulation of hepcidin expression.Nat Commun. 2025 Jul 1;16(1):5491. doi: 10.1038/s41467-025-61067-8. Nat Commun. 2025. PMID: 40593779 Free PMC article.
-
Role of zinc in health and disease.Clin Exp Med. 2024 Feb 17;24(1):38. doi: 10.1007/s10238-024-01302-6. Clin Exp Med. 2024. PMID: 38367035 Free PMC article. Review.
-
Mechanism and application prospect of ferroptosis inhibitors in improving osteoporosis.Front Endocrinol (Lausanne). 2024 Dec 13;15:1492610. doi: 10.3389/fendo.2024.1492610. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 39735645 Free PMC article. Review.
-
Modulation of the HIF-1α-NCOA4-FTH1 Signaling Axis Regulating Ferroptosis-induced Hepatic Stellate Cell Senescence to Explore the Anti-hepatic Fibrosis Mechanism of Curcumol.Curr Med Chem. 2024;31(19):2821-2837. doi: 10.2174/0109298673271261231213051410. Curr Med Chem. 2024. PMID: 38351696
References
-
- Manthey J., Shield K.D., Rylett M., Hasan O.S.M., Probst C., Rehm J. Global alcohol exposure between 1990 and 2017 and forecasts until 2030: a modelling study. Lancet. 2019;393:2493–2502. - PubMed
-
- Ganne-Carrié N., Christidis C., Chastang C., Ziol M., Chapel F., Imbert-Bismut F., Trinchet J.C., Guettier C., Beaugrand M. Liver iron is predictive of death in alcoholic cirrhosis: a multivariate study of 229 consecutive patients with alcoholic and/or hepatitis C virus cirrhosis: a prospective follow up study. Gut. 2000;46:277–282. - PMC - PubMed
-
- Eng S.C., Taylor S.L., Reyes V., Raaka S., Berger J., Kowdley K.V. Hepatic iron overload in alcoholic end-stage liver disease is associated with iron deposition in other organs in the absence of HFE-1 hemochromatosis. Liver Int. 2005;25:513–517. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical